Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

What will be the significance of this month’s 50th anniversary meeting at the famed Pacific Grove conference centre in ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise ...

Scientists are on a mission to resurrect the woolly mammoth by 2028, using cutting-edge genetic engineering and cloning ...

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

Recent innovations in DNA-modifying will revolutionize the treatment of many diseases and prompt crucial discussions.

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

The FDA has approved the first-ever clinical trials for pig kidney transplants in humans marking a breakthrough in tackling ...

The FDA has given approval for the first clinical trials of pig kidney transplants in humans, representing a significant ...